LOS ANGELES (March 28, 2000) -- Cedars-Sinai Medical Center's David L. Rimoin, M.D., Ph.D., has been appointed to serve on two committees that will influence national health policy over the next decade.
The Steven Spielberg Chairman of Pediatrics at Cedars-Sinai, Director of the Ahmanson Pediatric Center, and Director of the hospital's Genetics-Birth Defects Center, Dr. Rimoin has been invited to co-chair The Strategic Planning Task Force on genetics and developmental biology for the National Institute of Child Health and Human Development, an agency of the National Institutes of Health.
Commissioned to guide the decade's allocation of funding in the area of genetics and diseases that produce birth defects, this task force is expected to complete its work within the next year.
The second appointment is to The Clinical Research Round Table of the Institute of Medicine, an arm of the National Academy of Sciences. Dr. Rimoin is among 25 leaders from various elements of the health-care industry beginning a long-term assessment of issues related to clinical research funding, safety and regulatory matters.
In his positions at Cedars-Sinai, Dr. Rimoin manages all clinical, educational and research efforts related to the care of children, and he oversees a cross-departmental genetics program that consists of physicians and scientists doing research or providing clinical care for all forms of genetic disease.
Dr. Rimoin was the founding president of the American Board of Medical Genetics in 1979 and the American College of Medical Genetics in 1992.
For media information and to arrange an interview, please call 1-800-396-1002 . Thanks for not publishing this number in stories.